Press Releases from DelveInsight Business Research (5349 total)
Congenital Hyperinsulinism Market Poised for Significant Growth from 2024 to 203 …
The Congenital Hyperinsulinism market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Congenital…
Membranous Nephropathy Market Anticipated to Expand Rapidly During 2023-2032, Sa …
DelveInsight's "Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as…
NK Cell Therapy Pipeline 2025: Key Developments, Emerging Therapies, and Clinica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Nk Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk…
Angelman Syndrome Pipeline and Clinical Trials Assessment, 2025 Updates: FDA App …
Angelman Syndrome pipeline constitutes 10+ key companies continuously working towards developing 10+ Angelman Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route…
Seizures Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's "Seizures Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Seizures, historical and forecasted epidemiology as well as the…
Spinal Muscular Atrophy Clinical Trials and Pipeline 2025: EMA, PDMA, FDA Approv …
(Albany, USA) "Spinal Muscular Atrophy Pipeline Insight, 2025′′ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the…
Spasticity Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Med …
(Albany, USA) DelveInsight's "Spasticity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Spasticity, historical and forecasted epidemiology as well as the…
Tardive Dyskinesia Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approv …
(Albany, USA) DelveInsight's "Tardive Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Tardive Dyskinesia, historical and forecasted epidemiology as well…
Restless Leg Syndrome Drugs Market 2032: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "Restless Leg Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Restless Leg Syndrome, historical and forecasted…
Primary Progressive Multiple Sclerosis Clinical Trials and Pipeline 2025: EMA, P …
(Albany, USA) "Primary Progressive Multiple Sclerosis Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects…
Post-traumatic Stress Disorder Clinical Trials and Pipeline 2025: EMA, PDMA, FDA …
(Albany, USA) DelveInsight's 'Post-traumatic Stress Disorder Pipeline Insight 2025' report provides comprehensive global coverage of available, marketed, and pipeline PTSD therapies in various stages of…
Postherpetic Neuralgia Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Postherpetic Neuralgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Postherpetic Neuralgia, historical and forecasted epidemiology as…
Peripheral Neuropathic Pain Treatment Market 2034: Clinical Trials, EMA, PDMA, F …
(Albany, USA) DelveInsight's "Peripheral Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Peripheral Neuropathic Pain, historical and forecasted…
Partial Seizure Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …
(Albany, USA) DelveInsight's "Partial Seizure Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Partial Seizure, historical and forecasted epidemiology as well…
Cushing's Syndrome Pipeline 2025: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cushing's Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Cushing's Syndrome…
Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Traumatic Encephalopathy pipeline constitutes 4+ key companies continuously working towards developing 4+ Chronic…
Meibomian Gland Dysfunction Pipeline 2025: In-depth Clinical Trials Analysis and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Meibomian Gland Dysfunction pipeline constitutes 4+ key companies continuously working towards developing 4+ Meibomian…
Lupus Nephritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lupus Nephritis pipeline constitutes 35+ key companies continuously working towards developing 40+ Lupus Nephritis…
Cough in Idiopathic Pulmonary Pipeline 2025: FDA Updates, Therapy Innovations, a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cough in Idiopathic Pulmonary Fibrosis pipeline constitutes 5+ key companies continuously working towards developing…
Hyperuricemia Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MO …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hyperuricemia pipeline constitutes 12+ key companies continuously working towards developing 15+ Hyperuricemia treatment therapies,…
Stargardt Disease Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease…
Diabetic Neuropathic Pain Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Neuropathic Pain pipeline constitutes 10+ key companies continuously working towards developing 12+ Diabetic…
Diabetic Macular Edema Pipeline 2025: Therapies Under Investigation, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema…
Acute Myeloid Leukemia Pipeline 2025: MOA and ROA Insights, Clinical Trials Stat …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Myeloid Leukemia pipeline constitutes 110+ key companies continuously working towards developing 120+ Acute…
Vascular Dementia Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, …
(Albany, USA) DelveInsight's 'Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as…
Acute Ischemic Stroke Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acute Ischemic Stroke, historical and forecasted…
Alzheimer's Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Appro …
(Albany, USA) DelveInsight's "Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Alzheimer's Disease, historical and forecasted epidemiology as well…
Amyotrophic Lateral Sclerosis Market Forecast 2034: FDA, EMA, PDMA Approvals, Cl …
(Albany, USA) DelveInsight's "Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Amyotrophic Lateral Sclerosis, historical and forecasted epidemiology…
Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market 2032: Clinical …
(Albany, USA) DelveInsight's "Attention Deficit Hyperactivity Disorder Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Attention Deficit Hyperactivity Disorder, historical…
Fibromyalgia Treatment Market 2034: Clinical Trials, FDA, EMA, PDMA Approvals, M …
(Albany, USA) DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as…
Migraine Treatment Market 2034: Clinical Trials, FDA, EMA, PDMA Approvals, Medic …
(Albany, USA) DelveInsight's "Migraine Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as…
Major depressive disorder Drugs Market 2034: Clinical Trials, Medication, Pipeli …
(Albany, USA) DelveInsight's "Major depressive disorder Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Major depressive disorder, historical and forecasted epidemiology…
Fanconi Anemia Pipeline 2025: FDA Approvals and Clinical Trials Landscape with M …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Fanconi Anemia pipeline constitutes 3+ key companies continuously working towards developing 3+ Fanconi Anemia…
Clostridium Difficile Infections Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium…
Nontuberculous Mycobacterial Infections Pipeline 2025: Therapies Under Investiga …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Nontuberculous Mycobacterial Infections pipeline constitutes 10+ key companies continuously working towards developing 10+ Nontuberculous…
Hepatitis D Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatitis D pipeline constitutes 6+ key companies continuously working towards developing 6+ Hepatitis D…
Hepatitis C Virus Infection Pipeline 2025: FDA Updates, Therapy Innovations, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatitis C Virus Infection pipeline constitutes 20+ key companies continuously working towards developing 20+…
Sarcopenia Market Expected to Experience Major Growth by 2034, According to Delv …
DelveInsight's "Sarcopenia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia…
Chronic Spontaneous Urticaria Market Set to Grow Substantially Through 2034, Del …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as…
Chronic Kidney Disease Market to Show Remarkable Growth Trends from 2024 to 2034 …
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Beta Thalassemia Market Predicted to See Upsurge Through 2034, Highlights DelveI …
DelveInsight's "Beta Thalassemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Beta Thalassemia, historical and forecasted epidemiology as well as…
Glioblastoma Multiforme Market Growth to Accelerate in Forecast Period (2024-203 …
DelveInsight's "Glioblastoma Multiforme Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Glioblastoma Multiforme, historical and forecasted epidemiology as well as…
Migraine Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Pipeline, T …
(Albany, United States) As per DelveInsight's assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies, analysis of Clinical…
Neuropathic Pain Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Cl …
(Albany, USA) DelveInsight's "Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Neuropathic Pain, historical and forecasted epidemiology as well…
Obsessive Compulsive Disorder Clinical Trials 2025: EMA, PDMA, FDA Approvals, Me …
(Albany, United States) As per DelveInsight's assessment, globally, Obsessive Compulsive Disorder pipeline constitutes 5+ key companies continuously working towards developing 5+ Obsessive Compulsive Disorder treatment…
Marginal Zone Lymphoma Pipeline 2025: MOA and ROA Insights, Clinical Trials Stat …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Marginal Zone Lymphoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Marginal…
Spinal Cord Injury Pipeline 2025: Key Developments, Emerging Therapies, and Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinal Cord Injury pipeline constitutes 25+ key companies continuously working towards developing 30+ Spinal…
Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical Trials Landscape wi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Endometriosis Pain pipeline constitutes 5+ key companies continuously working towards developing 5+ Endometriosis Pain…
Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA Insights, and Key Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias…
Diabetic Kidney Disease Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease…
